187 related articles for article (PubMed ID: 24046089)
1. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and risk of glioma.
Zhang F; Li D; Li Y; Li H; Sun J; Li X; Li X
Tumour Biol; 2014 Jan; 35(1):747-51. PubMed ID: 24046089
[TBL] [Abstract][Full Text] [Related]
2. Quantitative assessment of the association between TP53 Arg72Pro polymorphism and bladder cancer risk.
Liu ZH; Bao ED
Mol Biol Rep; 2013 Mar; 40(3):2389-95. PubMed ID: 23184052
[TBL] [Abstract][Full Text] [Related]
3. Association between p53 Arg72Pro polymorphism and thyroid cancer risk: a meta-analysis.
Wu B; Guo D; Guo Y
Tumour Biol; 2014 Jan; 35(1):561-5. PubMed ID: 24037912
[TBL] [Abstract][Full Text] [Related]
4. Association between TP53 Arg72Pro polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Xu CT; Zheng F; Dai X; Du JD; Liu HR; Zhao L; Li WM
Asian Pac J Cancer Prev; 2012; 13(9):4305-9. PubMed ID: 23167333
[TBL] [Abstract][Full Text] [Related]
5. Association between TP53 Arg72Pro polymorphism and thyroid carcinoma risk.
Wang F; Wang P; Wang B; Fu ZJ; Yuan Y; Yan SL; Zhao WJ; Wang YG
Tumour Biol; 2014 Mar; 35(3):2723-8. PubMed ID: 24375191
[TBL] [Abstract][Full Text] [Related]
6. Association between the TP53 codon 72 polymorphism and risk of oral squamous cell carcinoma in Asians: a meta-analysis.
Zeng XT; Luo W; Geng PL; Guo Y; Niu YM; Leng WD
BMC Cancer; 2014 Jun; 14():469. PubMed ID: 24969046
[TBL] [Abstract][Full Text] [Related]
7. Association between the p53 codon 72 Arg/Pro polymorphism and hepatocellular carcinoma risk.
Lv L; Wang P; Zhou X; Sun B
Tumour Biol; 2013 Jun; 34(3):1451-9. PubMed ID: 23564481
[TBL] [Abstract][Full Text] [Related]
8. Association between TP53 Arg72Pro polymorphism and leukemia risk: a meta-analysis of 14 case-control studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Sci Rep; 2016 Apr; 6():24097. PubMed ID: 27053289
[TBL] [Abstract][Full Text] [Related]
9. The association between the TP53 Arg72Pro polymorphism and colorectal cancer: An updated meta-analysis based on 32 studies.
Tian X; Dai S; Sun J; Jiang S; Jiang Y
Oncotarget; 2017 Jan; 8(1):1156-1165. PubMed ID: 27901479
[TBL] [Abstract][Full Text] [Related]
10. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: a meta-analysis.
Jiang DK; Yao L; Wang WZ; Peng B; Ren WH; Yang XM; Yu L
World J Gastroenterol; 2011 Mar; 17(9):1227-33. PubMed ID: 21448430
[TBL] [Abstract][Full Text] [Related]
11. The effects of p53 Arg72Pro polymorphism on glioma susceptibility: a meta-analysis.
Zhu W; Lu L; Li Y; Yao J; Xu B
Tumour Biol; 2014 Apr; 35(4):3725-30. PubMed ID: 24488625
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis of association between the TP53 Arg72Pro polymorphism and risk of endometriosis based on case-control studies.
Yan Y; Wu R; Li S; He J
Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():1-7. PubMed ID: 25819169
[TBL] [Abstract][Full Text] [Related]
13. Associations between P53 Arg72Pro and development of digestive tract cancers: a meta-analysis.
Liu L; Wang K; Zhu ZM; Shao JH
Arch Med Res; 2011 Jan; 42(1):60-9. PubMed ID: 21376265
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk.
Shen SQ; Jiang DK; Liu GY; Chen F; Yu L
Mol Biol Rep; 2012 Apr; 39(4):4683-90. PubMed ID: 21952824
[TBL] [Abstract][Full Text] [Related]
15. Association between TP53 gene codon72 polymorphism and prostate cancer risk: A systematic review and meta-analysis.
Han PZ; Cao DH; Zhang XL; Ren ZJ; Wei Q
Medicine (Baltimore); 2019 Jun; 98(25):e16135. PubMed ID: 31232967
[TBL] [Abstract][Full Text] [Related]
16. The relationship between leukemia and
Drokow EK; Chen Y; Waqas Ahmed HA; Oppong TB; Akpabla GS; Pei Y; Kumah MA; Neku EA; Sun K
Future Oncol; 2020 May; 16(14):923-937. PubMed ID: 32301350
[No Abstract] [Full Text] [Related]
17. p53 codon 72 polymorphism and hematological cancer risk: an update meta-analysis.
Weng Y; Lu L; Yuan G; Guo J; Zhang Z; Xie X; Chen G; Zhang J
PLoS One; 2012; 7(9):e45820. PubMed ID: 23029260
[TBL] [Abstract][Full Text] [Related]
18. Pro variant of TP53 Arg72Pro contributes to esophageal squamous cell carcinoma risk: evidence from a meta-analysis.
Wang B; Wang D; Zhang D; Li A; Liu D; Liu H; Jin H
Eur J Cancer Prev; 2010 Jul; 19(4):299-307. PubMed ID: 20389250
[TBL] [Abstract][Full Text] [Related]
19. Association between the P53 codon 72 polymorphism and nasopharyngeal cancer risk.
Cai K; Wang Y; Zhao X; Bao X
Tumour Biol; 2014 Mar; 35(3):1891-7. PubMed ID: 24114013
[TBL] [Abstract][Full Text] [Related]
20. TP53 and MDM2 gene polymorphisms, gene-gene interaction, and hepatocellular carcinoma risk: evidence from an updated meta-analysis.
Peng Q; Lao X; Chen Z; Lai H; Deng Y; Wang J; Mo C; Sui J; Wu J; Zhai L; Yang S; Qin X; Li S
PLoS One; 2013; 8(12):e82773. PubMed ID: 24376578
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
